Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.
Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Gujarat Themis Biosyn OCF Yield % Related Terms
Gujarat Themis Biosyn OCF Yield % Historical Data
* Premium members only.
The historical data trend for Gujarat Themis Biosyn's OCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Gujarat Themis Biosyn's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Gujarat Themis Biosyn OCF Yield % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Gujarat Themis Biosyn's OCF Yield % distribution charts can be found below:
* The bar in red indicates where Gujarat Themis Biosyn's OCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Gujarat Themis Biosyn (BOM:506879) has a OCF Yield % of 1.18 as of Jul. 14, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Gujarat Themis Biosyn and its competitors. Over the past decade, Gujarat Themis Biosyn's OCF Yield % has ranged from 1.18 to 1.18. According to the industry distribution chart, Gujarat Themis Biosyn ranks #640 out of 1007 companies in the Drug Manufacturers industry, placing it in the top 63.6%.
Is Gujarat Themis Biosyn's OCF Yield % too high?
Gujarat Themis Biosyn's current OCF Yield % is 1.18. Over the past 10 years, this metric has ranged from a low of 1.18 to a high of 1.18. The Drug Manufacturers industry median OCF Yield % is 3.53. Gujarat Themis Biosyn's value of 1.18 is 66.6% below this industry median. Based on the distribution chart, Gujarat Themis Biosyn ranks #640 out of 1007 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Gujarat Themis Biosyn has a GF Score™ of 76/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Gujarat Themis Biosyn's OCF Yield % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Gujarat Themis Biosyn ranks #640 out of 1007 companies for OCF Yield %. This places Gujarat Themis Biosyn in the lower half of its industry. The industry median OCF Yield % is 3.53. Gujarat Themis Biosyn's value of 1.18 is 66.6% below this benchmark. Historically, Gujarat Themis Biosyn's own OCF Yield % has ranged from 1.18 to 1.18 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Drug Manufacturers company?
The median OCF Yield % among Drug Manufacturers companies is 3.53, based on 1,007 companies in the industry. Companies in the top quartile (top 25%) have a OCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Gujarat Themis Biosyn's current OCF Yield % of 1.18 is 66.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Gujarat Themis Biosyn and its competitors. For the Drug Manufacturers industry, the median OCF Yield % is 3.53 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Gujarat Themis Biosyn's current OCF Yield % is 1.18. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Gujarat Themis Biosyn stock overvalued right now?
Based on GuruFocus' analysis, Gujarat Themis Biosyn (BOM:506879) is currently considered Modestly Overvalued. The stock's GF Value™ is ₹313.37, compared to a current price of ₹381.25 — trading 21.7% above its estimated fair value. The current OCF Yield % is 1.18 and 66.6% below the Drug Manufacturers industry median of 3.53. Gujarat Themis Biosyn's overall GF Score™ is 76/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For Gujarat Themis Biosyn (BOM:506879), the current OCF Yield % is 1.18 as of Jul. 14, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Gujarat Themis Biosyn (BOM:506879) Overvalued in 2026?
Based on GuruFocus' analysis, Gujarat Themis Biosyn stock appears to be overvalued.
The current stock price of ₹381.25 is trading 21.7% above its estimated GF Value™ of ₹313.37.
GuruFocus considers Gujarat Themis Biosyn to be Modestly Overvalued.
Key valuation signals for BOM:506879:
OCF Yield %: 1.18
GF Value™: ₹313.37 vs. price of ₹381.25 (21.7% above fair value)
Industry Position: 66.6% below the Drug Manufacturers median (#640 of 1007)
No single metric tells the full story. See the BOM:506879 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Gujarat Themis Biosyn Ltd is engaged in manufacturing, exporting, and selling of bulk drugs on a job-work basis. The company operates in one segment which is pharmaceuticals. Its products include Rifamycin-S, which is an intermediate for Rifampicin for the treatment of tuberculosis (TB), and Lovastatin.
76GF Score
Get the complete analysis for BOM:506879
OCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:506879 has been successfully added to your 
